NCT07185009: A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- State
- Under way
- Phase
- Phase 3
- People
- 751 planned
- Started
- 16 Jan 2026
- Primary completion
- 21 Sep 2028
- Arms
- Duvakitug - dose 1, Duvakitug - dose 2, Duvakitug - dose 3
- Results
- None posted
- 22 Sep 2025: Trial registered
- 16 Jan 2026: Trial started